Skip to content
healthcare.dev

WAINUA

NDC 0310-9400, EPLONTERSEN, injection, solution, from AstraZeneca Pharmaceuticals LP.

Product NDC
0310-9400
Status
Listed
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217388
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0310-9400 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EPLONTERSEN45 mg/.8mL

Pharmacologic classes

Antisense Oligonucleotide [EPC]; Decreased RNA Integrity [PE]; Increased Protein Breakdown [PE]; Oligonucleotides, Antisense [CS]; Transthyretin-directed RNA Interaction [EPC]

Package NDCNDC-11Package
0310-9400-01003109400011 SYRINGE, GLASS in 1 CARTON (0310-9400-01) / .8 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d7dcb847-71dd-4fff-82d0-d43a465fc096

Use it

Look up 0310-9400 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0310-9400 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0310-9400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.